Literature DB >> 11698635

Use of subcutaneous venous access ports to treat refractory ascites.

D I Rosenblum1, M A Geisinger, J S Newman, T M Boden, D Markowitz, D Powell, K D Mullen.   

Abstract

To assess the feasibility of peritoneal ports for management of patients with cirrhotic refractory ascites, 10 ports were placed in nine patients for frequent outpatient paracentesis. Retrospective review and telephone interviews were used to assess port performance. Kaplan-Meier analysis revealed a median duration of port patency of 255 days. In 1,557 port days, four access problems prompted further interventional evaluation. Three cases of bacterial peritonitis and one catheter obstruction developed. The use of subcutaneous venous access ports to allow control of ascites by nursing personnel is a promising alternative for management of patients with refractory ascites. Additional studies are needed to determine long-term effectiveness and safety.

Entities:  

Mesh:

Year:  2001        PMID: 11698635     DOI: 10.1016/s1051-0443(07)61561-9

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  5 in total

1.  Treatment of refractory ascites.

Authors:  Praveena G Velamati; H Franklin Herlong
Journal:  Curr Treat Options Gastroenterol       Date:  2006

2.  Central venous pressure catheter for large-volume paracentesis in refractory ascites.

Authors:  Shahram Agah; Sahar Tavakoli; Hajar Nikbakht; Mehrdokht Najafi; Abdolreza Al-Agha
Journal:  Indian J Gastroenterol       Date:  2014-04-24

Review 3.  Permanent catheters for recurrent ascites-a critical and systematic review of study methodology.

Authors:  Lars Christensen; Lorna Wildgaard; Kim Wildgaard
Journal:  Support Care Cancer       Date:  2016-03-01       Impact factor: 3.603

4.  Percutaneous management of malignant fluid collections.

Authors:  Leann S Stokes
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

5.  Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system.

Authors:  Ihsan Inan; Sandra De Sousa; Patrick O Myers; Brigitte Bouclier; Pierre-Yves Dietrich; Monica E Hagen; Philippe Morel
Journal:  World J Surg Oncol       Date:  2008-08-18       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.